Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Hydralazine, sold under the brand name Apresoline among others, is a medication used to treat high blood pressure and heart failure. This includes high blood pressure in pregnancy and very high blood pressure resulting in symptoms. It has been found to be particularly useful in heart failure, together with isosorbide dinitrate, for treatment of people of…
Applications, Research, Art & Standards
Explore the main themes, entities and connections around Hydralazine. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
heart effects blood used treatment may pressure failure people drugs treat side include disease pregnancy mouth action drug also muscle
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Hydralazine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Hydralazine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Hydralazine | ATC code | C02DB02 (WHO) | 1.00 | infobox |
| Hydralazine | Bioavailability | 26–50% | 1.00 | infobox |
| Hydralazine | CAS Number | 86-54-4 Y | 1.00 | infobox |
| Hydralazine | ChEBI | CHEBI:5775 Y | 1.00 | infobox |
| Hydralazine | ChEMBL | ChEMBL276832 Y | 1.00 | infobox |
| Hydralazine | ChemSpider | 3511 Y | 1.00 | infobox |
| Hydralazine | CompTox Dashboard (EPA) | DTXSID4023129 | 1.00 | infobox |
| Hydralazine | DrugBank | DB01275 Y | 1.00 | infobox |
| Hydralazine | Duration of action | 2–6 hours | 1.00 | infobox |
| Hydralazine | ECHA InfoCard | 100.001.528 | 1.00 | infobox |
| Hydralazine | Elimination half-life | 2–8 hours, 7–16 hours (renal impairment) | 1.00 | infobox |
| Hydralazine | Excretion | Urine | 1.00 | infobox |
| Hydralazine | Formula | C8H8N4 | 1.00 | infobox |
| Hydralazine | IUPHAR/BPS | 7326 | 1.00 | infobox |
| Hydralazine | KEGG | D08044 Y | 1.00 | infobox |
| Hydralazine | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Hydralazine | Legal status | CA: ℞-only | 1.00 | infobox |
| Hydralazine | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Hydralazine | Legal status | US: ℞-only | 1.00 | infobox |
| Hydralazine | License data | US DailyMed: Hydralazine | 1.00 | infobox |
| Hydralazine | MedlinePlus | a682246 | 1.00 | infobox |
| Hydralazine | Metabolism | Liver | 1.00 | infobox |
| Hydralazine | Molar mass | 160.180 g·mol−1 | 1.00 | infobox |
| Hydralazine | Onset of action | 5–30 minutes | 1.00 | infobox |
| Hydralazine | Pregnancy category | AU: C | 1.00 | infobox |
| Hydralazine | Protein binding | 85–90% | 1.00 | infobox |
| Hydralazine | PubChem CID | 3637 | 1.00 | infobox |
| Hydralazine | Routes of administration | By mouth, intravenous | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.